Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967

July 29, 2021

Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC

July 29, 2021

Targeting the IL-8/CXCR2 axis as a potential therapeutic strategy in prostate cancer

July 29, 2021

New serine-protein kinase ATM inhibitors described by Medshine Discovery

July 29, 2021

First patients dosed in new studies of Xpovio in melanoma and myelofibrosis

July 29, 2021

New RORgammaT agonists identified at Sunshine Lake Pharma

July 29, 2021

Ipsen and BAKX Therapeutics partner on BKX-001

July 28, 2021

Mouse model shows targeting RagC GTPase could safely treat B-cell lymphomas

July 28, 2021

New phase II trial evaluates Orpathsys for advanced or metastatic MET-amplified gastric cancer

July 28, 2021

Infinity reports data on eganelisib in combination therapy for urothelial cancer and TNBC

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...